A conference abstract presented at the European Society for Medical Oncology (ESMO) 2025 meeting looks at adjuvant chemotherapy given in stage III colon cancer. Prof Andrew Beggs, MRC Senior Clinical ...

Colon cancer recurrence risk falls below 0.5% at 6 years post-surgery, offering a practical benchmark for defining cure, according to new research.

“ur finding enables the safe discontinuation of follow-up after 6 years, leading to an improvement in quality of life and a reduction in health care system costs,” study researchers wrote.

Taking aspirin on a daily basis protects against the recurrence of colon cancer, a new study found. People who took aspirin every day for three years had a 55% reduced risk of colorectal cancer tumors ...

A new UCLA Health study found that taking an 8-strain probiotic daily may reduce the risk of pouchitis, a common inflammatory condition that occurs after colon removal surgery for ulcerative colitis, ...

A new UCLA Health study found that taking an eight-strain probiotic daily may reduce the risk of pouchitis, a common inflammatory condition that occurs after colon removal surgery for ulcerative ...